208 related articles for article (PubMed ID: 31009857)
1. The association between metformin therapy and risk of gynecological cancer in patients: Two meta-analyses.
Wen Q; Zhao Z; Wen J; Zhou J; Wu J; Lei S; Miao Y
Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():33-41. PubMed ID: 31009857
[TBL] [Abstract][Full Text] [Related]
2. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
[TBL] [Abstract][Full Text] [Related]
3. Association between metformin therapy and incidence, recurrence and mortality of prostate cancer: evidence from a meta-analysis.
Deng D; Yang Y; Tang X; Skrip L; Qiu J; Wang Y; Zhang F
Diabetes Metab Res Rev; 2015 Sep; 31(6):595-602. PubMed ID: 25708557
[TBL] [Abstract][Full Text] [Related]
4. Old drug, new trick: repurposing metformin for gynecologic cancers?
Febbraro T; Lengyel E; Romero IL
Gynecol Oncol; 2014 Dec; 135(3):614-21. PubMed ID: 25455733
[TBL] [Abstract][Full Text] [Related]
5. Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.
Thakkar B; Aronis KN; Vamvini MT; Shields K; Mantzoros CS
Metabolism; 2013 Jul; 62(7):922-34. PubMed ID: 23419783
[TBL] [Abstract][Full Text] [Related]
6. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
Nie Z; Zhu H; Gu M
Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
[TBL] [Abstract][Full Text] [Related]
7. Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis.
Tang YL; Zhu LY; Li Y; Yu J; Wang J; Zeng XX; Hu KX; Liu JY; Xu JX
Biomed Res Int; 2017; 2017():5905384. PubMed ID: 28409158
[TBL] [Abstract][Full Text] [Related]
8. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
Wang Z; Lai ST; Xie L; Zhao JD; Ma NY; Zhu J; Ren ZG; Jiang GL
Diabetes Res Clin Pract; 2014 Oct; 106(1):19-26. PubMed ID: 24837144
[TBL] [Abstract][Full Text] [Related]
9. Relationship between metformin therapy and risk of colorectal cancer in patients with diabetes mellitus: a meta-analysis.
Yang WT; Yang HJ; Zhou JG; Liu JL
Int J Colorectal Dis; 2020 Nov; 35(11):2117-2131. PubMed ID: 32720184
[TBL] [Abstract][Full Text] [Related]
10. Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
Liu F; Yan L; Wang Z; Lu Y; Chu Y; Li X; Liu Y; Rui D; Nie S; Xiang H
Oncotarget; 2017 Feb; 8(9):16017-16026. PubMed ID: 27926481
[TBL] [Abstract][Full Text] [Related]
11. Metformin Use and Lung Cancer Risk in Diabetic Patients: A Systematic Review and Meta-Analysis.
Yao L; Liu M; Huang Y; Wu K; Huang X; Zhao Y; He W; Zhang R
Dis Markers; 2019; 2019():6230162. PubMed ID: 30881522
[TBL] [Abstract][Full Text] [Related]
12. Metformin for prevention of hypertensive disorders of pregnancy in women with gestational diabetes or obesity: systematic review and meta-analysis of randomized trials.
Kalafat E; Sukur YE; Abdi A; Thilaganathan B; Khalil A
Ultrasound Obstet Gynecol; 2018 Dec; 52(6):706-714. PubMed ID: 29749110
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis.
Zhang ZJ; Li S
Diabetes Obes Metab; 2014 Aug; 16(8):707-10. PubMed ID: 24460896
[TBL] [Abstract][Full Text] [Related]
14. Association Between Metformin Use and the Risk, Prognosis of Gynecologic Cancer.
Yao K; Zheng H; Li T
Front Oncol; 2022; 12():942380. PubMed ID: 35898873
[TBL] [Abstract][Full Text] [Related]
15. Impact of endometriosis on risk of ovarian, endometrial and cervical cancers: a meta-analysis.
Li J; Liu R; Tang S; Feng F; Liu C; Wang L; Zhao W; Zhang T; Yao Y; Wang X; Sun C
Arch Gynecol Obstet; 2019 Jan; 299(1):35-46. PubMed ID: 30460611
[TBL] [Abstract][Full Text] [Related]
16. Short- and long-term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta-analysis.
Butalia S; Gutierrez L; Lodha A; Aitken E; Zakariasen A; Donovan L
Diabet Med; 2017 Jan; 34(1):27-36. PubMed ID: 27150509
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review.
Saka Herrán C; Jané-Salas E; Estrugo Devesa A; López-López J
Oral Oncol; 2018 Oct; 85():68-81. PubMed ID: 30220322
[TBL] [Abstract][Full Text] [Related]
18. Risk of Skin Cancer Associated with Metformin Use: A Meta-Analysis of Randomized Controlled Trials and Observational Studies.
Chang MS; Hartman RI; Xue J; Giovannucci EL; Nan H; Yang K
Cancer Prev Res (Phila); 2021 Jan; 14(1):77-84. PubMed ID: 32958585
[TBL] [Abstract][Full Text] [Related]
19. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
Tseng CH
Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
[TBL] [Abstract][Full Text] [Related]
20. Association between Different Types of Tea Consumption and Risk of Gynecologic Cancer: A Meta-Analysis of Cohort Studies.
Zheng F; Chen K; Zhong J; Tang S; Xu S; Lu W; Wu Y; Xia D
Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
